About Dr. Garrett W. Lindemann

Lindemann Research Consulting, Inc | Dr. Garrett W. Lindemann

As the founder and President of Lindemann Research Consulting Inc., Garrett W. Lindemann, Ph.D., leverages more than a decade of experience to assist developed, developing and start-up companies in the biotechnology and pharmaceutical industries. Today, Lindemann Research Consulting is recognized worldwide as an organization dedicated to providing an array of business and product development and management services for both large and small biotechnology and pharmaceutical companies.

Prior to founding Lindemann Research Consulting in 2004, Dr. Lindemann was the Executive Vice President of Research and Development for a start-up Pharmaceutical Company where he was responsible for drug development (Clinical and Pre-Clinical) and the patent portfolio as well as technology strategy (2001-2004). Previously, he has managed and led research teams and performed technology assessment for the Chief Technology Office of Roche Diagnostics (1995-2001).

Dr. Lindemann holds a Ph.D. in Molecular Genetics from the University of Kansas (Lawrence, Kansas) and a B.S. in Biology from Saint John's University (Collegeville, Minnesota). As a research scientist he has made contributions in the areas of gene isolation, gene expression, cellular localization, image analysis, and drug development. In addition to his academic papers, Dr. Lindemann has authored technical documents that have been published and distributed internally within the ranks of client pharmaceutical and biotechnology companies. He is also an inventor on several pending and granted patents.